Windtree Therapeutics News

Immutep, Capricor Therapeutics, Cyclacel Pharmaceuticals Among Healthcare Movers

Seeking AlphaApr 24 10:00 ET

(WINT) - Analyzing Windtree Therapeutics's Short Interest

Windtree Therapeutics's (NYSE:WINT) short percent of float has risen 30.3% since its last report. The company recently reported that it has 39 thousand shares sold short, which is 0.43% of all regular

BenzingaApr 23 11:00 ET

Lexicon Pharmaceuticals, Bio-Path Holdings, Protara Therapeutics Among Healthcare Movers

Seeking AlphaApr 22 10:01 ET

Express News | Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Moomoo 24/7Apr 22 08:55 ET

Windtree Therapeutics To Carry Out 1-for-18 Reverse Stock Split On April 22nd, 2024

April 19th - $Windtree Therapeutics(WINT.US)$ is about to implement a 1-for-18 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from April 22nd, 2024.$Windtree Th

moomoo NewsApr 18 19:40 ET

Why Windtree Therapeutics (WINT) Stock Is Getting Hammered

Windtree Therapeutics Inc (NASDAQ:WINT) shares are trading lower by 20% to $0.32 during Thursday's session after the company announced it approved a 1-for-18 reverse stock split of its common stock. T

BenzingaApr 18 13:27 ET

Express News | Windtree Therapeutics Shares Are Trading Lower After the Company Approved a 1-for-18 Reverse Stock Split

Moomoo 24/7Apr 18 13:23 ET

Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Las Vegas Sands Corp. (NYSE:LVS) fell sharply during Thursday's session despite better-than-expected first-quarter results.The company reported quarterly adjusted earnings of 75 cents per sh

BenzingaApr 18 11:32 ET

Express News | Windtree Therapeutics Inc: Approved a 1-for-18 Reverse Stock Split of Its Issued and Outstanding Common Stock, Par Value of $0.001 per Share

Moomoo 24/7Apr 18 08:05 ET

Express News | Windtree Therapeutics Announces 1-for-18 Reverse Stock Split Effective April 22

Moomoo 24/7Apr 18 08:02 ET

Windtree Therapeutics: Split Will Increase Market Price Per Shr of Company's Common Stk, Bringing Co Into Compliance With Listing Requirements of $1 Minimum Bid Price Requirement by Nasdaq Cap Market >WINT

Windtree Therapeutics: Split Will Increase Market Price Per Shr of Company's Common Stk, Bringing Co Into Compliance With Listing Requirements of $1 Minimum Bid Price Requirement by Nasdaq Cap Market

Dow JonesApr 18 08:02 ET

Express News | Windtree Therapeutics Announces Reverse Stock Split

Moomoo 24/7Apr 18 08:00 ET

Express News | Windtree Therapeutics Q4 2023 GAAP EPS $(0.95) Misses $(0.94) Estimate

Moomoo 24/7Apr 17 08:19 ET

Windtree Therapeutics: Cash and Cash Equivalents $4.3M as at Dec. 31 >WINT

Windtree Therapeutics: Cash and Cash Equivalents $4.3M as at Dec. 31 >WINT

Dow JonesApr 17 08:02 ET

Express News | Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates

Moomoo 24/7Apr 17 08:00 ET

Windtree Therapeutics 4Q Loss/Shr 95c >WINT

Windtree Therapeutics 4Q Loss/Shr 95c >WINT

Dow JonesApr 17 08:00 ET

Express News | Windtree Therapeutics Inc - Qtrly Net Loss per Common Share Basic and Diluted $0.95

Moomoo 24/7Apr 17 07:34 ET

Express News | Windtree Therapeutics Shares Are Trading Lower. The Company Announced That It Entered Into an Asset Purchase Agreement With Varian Biopharmaceuticals to Acquire Certain Assets

Moomoo 24/7Apr 9 15:53 ET

Windtree Therapeutics to Acquire Cancer Treatment From Varian Biopharmaceuticals

Windtree Therapeutics (WINT) said Monday it has agreed to acquire a cancer treatment therapy from Varian Biopharmaceuticals. The therapy from Varian, which comes in oral and topical forms, is a protei

MT NewswiresApr 9 05:40 ET

Express News | Windtree Enter Asset Purchase Agreement With Varian Biopharmaceuticals To Acquire Certain Of Its Assets, Including A Proprietary Atypical Protein Kinase C Iota Inhibitor

Moomoo 24/7Apr 8 16:51 ET